ZYG11BL inhibitors are a chemical class that target the ZYG11B-like (ZYG11BL) protein, a homolog of the ZYG11 family involved in protein ubiquitination. ZYG11BL belongs to the ubiquitin-proteasome system (UPS), a complex cellular mechanism responsible for degrading and recycling proteins, ensuring proper cellular function and regulation. The ZYG11 family, including ZYG11BL, acts as substrate adaptors that help recognize and tag certain proteins for degradation. Inhibitors of ZYG11BL are designed to interfere with this recognition and tagging process, potentially leading to altered protein degradation patterns within cells. The inhibition of ZYG11BL can have significant effects on cellular homeostasis, influencing protein turnover, signaling pathways, and cell cycle progression.
These inhibitors can be useful tools in studying the functional dynamics of the ubiquitin-proteasome system, particularly in the context of understanding how specific proteins are targeted for degradation. By inhibiting ZYG11BL, researchers can gain insights into the biological roles of proteins that rely on this degradation pathway, which can have widespread effects on cellular processes such as metabolism, growth, and stress responses. Furthermore, ZYG11BL inhibitors can help elucidate the complex interactions between the components of the UPS and how they are regulated at different stages of protein life cycles. These inhibitors offer a valuable approach for probing protein homeostasis mechanisms, which are critical for maintaining cellular integrity in various biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can hinder protein degradation pathways in which ZYG11BL may be involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter signaling pathways and may indirectly affect ZYG11BL-involved processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can disrupt cellular growth pathways potentially linked to ZYG11BL activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can inhibit calcineurin, possibly affecting ZYG11BL through altered signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can modify inflammatory response pathways in which ZYG11BL may play a role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, which can affect MAPK/ERK pathways and thus potentially ZYG11BL's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which can alter stress response pathways possibly involving ZYG11BL. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can affect protein degradation systems, potentially impacting ZYG11BL. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which can disrupt MAPK/ERK signaling pathways, possibly affecting ZYG11BL. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can impact various signaling pathways and potentially modulate ZYG11BL activity. | ||||||